StonvexLoading…
StonvexStonvexStonvexCore line items from CAT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $19.44B | $17.41B | $67.59B | $48.46B | $30.82B |
Operating Income | Not available | $3.08B | $11.15B | $8.49B | $5.44B |
Net Income | Not available | $2.55B | $8.88B | $6.48B | $4.18B |
EPS (Diluted) | $6.14 | $5.47 | $18.81 | $13.69 | $8.82 |
Total Assets | Not available | $95.55B | $98.58B | $93.72B | $90.33B |
Total Liabilities | Not available | $76.89B | $77.27B | $73.06B | $71.66B |
Cash & Equivalents | Not available | $4.07B | $9.98B | $7.54B | $5.44B |
Free Cash Flow OCF − CapEx | Not available | $1.14B | $8.92B | $6.22B | $3.15B |
Shares Outstanding | Not available | 460.60M | 465.30M | 468.00M | 468.50M |